Company Profiles

driven by the PitchBook Platform

Celentyx

Description

Developing of therapies for treating diseases of the human immune system. The company's Immuno-Profilin platform allows analysis of drug action on human immune cells.

2007

Founded

PRIVATE

Status

11-50

Employees

Early Stage VC

Latest Deal Type

$121k

Latest Deal Amount

$121k

Total Amount Raised

Description

Developing of therapies for treating diseases of the human immune system. The company's Immuno-Profilin platform allows analysis of drug action on human immune cells.

Website:

www.celentyx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Discovery Tools (Healthcare)

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

Birmingham Research Park Vincent Drive, Edgbaston Birmingham B15 2SQEngland +44 (0)12 1414 8199
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Celentyx's full profile, request a free trial.

Celentyx Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Celentyx Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Celentyx Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Mercia TechnologiesVenture CapitalMinority000 0000000 0000
Spinner Matched Investment FundOtherMinority000 0000000 0000
West Midlands EnterpriseVenture CapitalMinority000 0000000 0000
Mercia Technologies Venture Capital
Spinner Matched Investment Fund Other
West Midlands Enterprise Venture Capital

Celentyx Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Nicholas Barnes Ph.DCo-Founder, Chief Executive Officer & Board Member
Catherine BradyChief Operating Officer
John GordonCo-Founder, Chief Scientific Officer & Board Member
Mark Bryant Ph.DChief Business Officer
Nicholas Barnes Ph.D Co-Founder, Chief Executive Officer & Board Member
Catherine Brady Chief Operating Officer
John Gordon Co-Founder, Chief Scientific Officer & Board Member
Mark Bryant Ph.D Chief Business Officer

Celentyx Board Members (4)

NameRepresentingRoleSinceContact
Info
Alan Boyd MDSelfBoard Member000 0000
Jonathan WatkinsSelfBoard Member000 0000
Mark ClementCelentyxBoard Observer000 0000
Mark Payton Ph.DMercia TechnologiesChief Executive Officer, Managing Director & Chief Investment Officer000 0000
Alan Boyd MD Board Member Self
Jonathan Watkins Board Member Self
Mark Clement Board Observer Celentyx
Mark Payton Ph.D Chief Executive Officer, Managing Director & Chief Investment Officer Mercia Technologies
Request full access to PitchBook